Literature DB >> 1719269

Anti-angiogenesis as a new concept for the therapy of neovascular diseases.

L Schweigerer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719269     DOI: 10.1007/bf01666825

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  6 in total

1.  Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.

Authors:  M Kusaka; K Sudo; T Fujita; S Marui; F Itoh; D Ingber; J Folkman
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

Review 2.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

Review 3.  Tumor angiogenesis: the role of oncogenes and tumor suppressor genes.

Authors:  N Bouck
Journal:  Cancer Cells       Date:  1990-06

4.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.

Authors:  D Ingber; T Fujita; S Kishimoto; K Sudo; T Kanamaru; H Brem; J Folkman
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

Review 5.  Vascular attack as a therapeutic strategy for cancer.

Authors:  J Denekamp
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

Review 6.  The fibroblast growth factor family: structural and biological properties.

Authors:  M Klagsbrun
Journal:  Prog Growth Factor Res       Date:  1989
  6 in total
  1 in total

1.  Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.

Authors:  C Engler; B Sander; J Villumsen; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.